1 LATANOPROST | 2610 of 5660 | 2040 prescriptions Less than 1% of all prescriptions | 1930 | 490 patients 17% of all patients | < 11 | |
2 PREDNISOLONE ACETATE | 1620 of 5470 | 1660 prescriptions Less than 1% of all prescriptions | | 1170 patients 41% of all patients | < 11 | |
3 TIMOLOL MALEATE | 1750 of 5180 | 970 prescriptions Less than 1% of all prescriptions | | 360 patients 13% of all patients | < 11 | |
4 DORZOLAMIDE-TIMOLOL (DORZOLAMIDE HCL/TIMOLOL MALEAT) | 1530 of 4280 | 310 prescriptions Less than 1% of all prescriptions | 310 | < 11 | < 11 | |
5 CIPROFLOXACIN HCL | 280 of 1060 | 830 prescriptions Less than 1% of all prescriptions | | 680 patients 24% of all patients | < 11 | A |
6 COMBIGAN (BRIMONIDINE TARTRATE/TIMOLOL) | 1020 of 3910 | 350 prescriptions Less than 1% of all prescriptions | | 120 patients 4% of all patients | < 11 | |
7 BRIMONIDINE TARTRATE | 1650 of 4720 | 240 prescriptions Less than 1% of all prescriptions | 240 | < 11 | < 11 | |
8 RESTASIS (CYCLOSPORINE) | 870 of 3630 | 320 prescriptions Less than 1% of all prescriptions | 320 | 130 patients 5% of all patients | 130 patients 5% of all patients | |
9 LUMIGAN (BIMATOPROST) | 1590 of 3660 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
10 NEOMYCIN-POLYMYXIN-DEXAMETH (NEOMYCIN/POLYMYXIN B/DEXAMETHA) | 790 of 2960 | 530 prescriptions Less than 1% of all prescriptions | | 380 patients 13% of all patients | < 11 | |
11 DORZOLAMIDE HCL | 1160 of 3330 | 130 prescriptions Less than 1% of all prescriptions | 130 | < 11 | < 11 | |
12 TRAVATAN Z (TRAVOPROST) | 1240 of 3340 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
13 ALPHAGAN P (BRIMONIDINE TARTRATE) | 1000 of 3220 | 140 prescriptions Less than 1% of all prescriptions | 140 | < 11 | < 11 | |
14 FLUOROMETHOLONE | 610 of 1640 | 120 prescriptions Less than 1% of all prescriptions | 120 | < 11 | < 11 | |
15 GATIFLOXACIN | 200 of 350 | 260 prescriptions Less than 1% of all prescriptions | 260 | 200 patients 7% of all patients | 200 patients 7% of all patients | |